Gachon University Gil Medical Center at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Gachon University Gil Medical Center takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on real-world use of lecanemab, including dosing strategies and schedule flexibility, and on how impaired arterial compliance relates to tau accumulation and neurodegeneration.

OrganizationCTAD 2026 Attendance
Hospitals & health systems
Teaching hospital of Gachon University in Incheon, South Korea.
Poster
Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue
Advanced Arterial Compliance Impairment Is Associated with Tau Accumulation and Progressive Neurodegeneration (P116)
Other mechanisms and targets · PET and MRI imaging · Presented remotely

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Gachon University Gil Medical Center

Tell us what you sell and we’ll find the people at Gachon University Gil Medical Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction